April 27, 2020 by Chain Drug Review
chief executive officer B. Douglas Hoey, COVID-19, NCPA
Leading Headlines, Pharmacy
ALEXANDRIA, Va. — As the coronavirus pandemic continues straining small business independent community pharmacies, 115 members of the U.S. House of Representatives are supporting a bipartisan push to include language permanently prohibiting pharmacy direct and indirect remuneration clawbacks by pharmacy benefit managers in future coronavirus relief packages. The letter was led by Reps. Buddy Carter
April 26, 2020 by Chain Drug Review
B. Douglas Hoey, COVID-19, Gov. Andrew Cuomo, NCPA
Leading Headlines, Pharmacy
ALEXANDRIA, Va. — The National Community Pharmacists Association, which represents over 21,000 independent pharmacies across the country, issued the following statement on behalf of CEO B. Douglas Hoey in response to New York Governor Andrew Cuomo’s executive order authorizing New York’s small business independent pharmacies to serve as COVID-19 testing collection centers: “We are deeply
April 20, 2020 by Chain Drug Review
COVID-19, Doug Hoey, NCPA
Leading Headlines, Pharmacy
ALEXANDRIA, Va. — Nearly 90% of community pharmacies will apply for small business federal aid under the CARES Act to help them get through the coronavirus storm, according to a new survey released Monday by the National Community Pharmacists Association. “Pharmacies are ‘essential businesses’ staying open during the COVID-19 pandemic to keep serving their communities,
April 8, 2020 by Chain Drug Review
chief executive officer B. Douglas Hoey, COVID-19, NCPA
Leading Headlines, Pharmacy
ALEXANDRIA, Va. — In a new video, National Community Pharmacists Association CEO B. Douglas Hoey, pharmacist, MBA, cheers community pharmacists on the front line of the fight against the coronavirus pandemic. Hoey applauds the pharmacists for being a safety net for their communities and thanks them for their hard work. “Community pharmacists are retooling their practices to
April 7, 2020 by Chain Drug Review
B. Douglas Hoey, COVID-19, NCPA
Leading Headlines, Pharmacy
ALEXANDRIA, Va. — A new nationwide analysis of pharmacies shows there are millions of Americans whose only option is a local independent, something policymakers and suppliers must keep in mind as they make their battle plans for COVID-19, said the National Community Pharmacists Association on Tuesday. “There are thousands of communities in which the only
March 30, 2020 by Chain Drug Review
COVID-19, NCPA, NCPA CEO B. Douglas Hoey
Leading Headlines, Pharmacy
ALEXANDRIA, Va. — Local pharmacists overwhelmingly disagree with recent actions by some states to limit the dispensing of a well-established malaria drug as a possible treatment for COVID-19, a new national survey shows. “Our members are clearly worried that this has become a political football,” said B. Douglas Hoey, CEO of the National Community Pharmacists
March 27, 2020 by Chain Drug Review
CARES Act, Karry La Violette, NCPA
Leading Headlines, Pharmacy
ALEXANDRIA, Va. — The National Community Pharmacists Association is urging passage of the Coronavirus Aid, Relief, and Economic Security (CARES) Act in a letter to leaders of the House of Representatives. The CARES Act contains protections that would help small businesses pharmacies survive the coronavirus pandemic. The legislation passed the Senate earlier this week and
March 16, 2020 by Jeffrey Woldt
Chuck Grassley, DIR fee reform, DIR fees, Medicaid, NCPA, Ron Wyden
March 16, 2020, Opinion
A new report on the cost of dispensing prescription medications brings into sharp focus the difficult economic challenges faced by retail pharmacy operators. It should come as no surprise that the study — conducted by Abt Associates and the MPI Group for the National Association of Chain Drug Stores, the National Community Pharmacists Association and
March 9, 2020 by Chain Drug Review
coronavirus, NCPA, NCPA CEO B. Douglas Hoey
Leading Headlines, Pharmacy
ALEXANDRIA, Va. – As the most accessible health care providers in many communities, neighborhood pharmacists are well-positioned to assist with efforts to curb and contain the coronavirus outbreak, the National Community Pharmacists Association said in a letter to the U.S. Department of Health and Human Services’ top emergency preparedness official. Dr. Robert Kadlec, the Assistant
March 5, 2020 by Chain Drug Review
2020 NICE Awards, NCPA, NCPA Innovation Center president Kurt Proctor, Sheila Warfield, sponsored by QS/1
Leading Headlines, Pharmacy
ALEXANDRIA, Va. – Seven community pharmacies have been named recipients of the 2020 NICE Awards, sponsored by QS/1, the National Community Pharmacists Association announced today. This is the third year of the NICE Awards competition, which was created to recognize pharmacies for their efforts to enhance their value, promote their services, and better serve their
March 3, 2020 by Chain Drug Review
2020 Cost of Dispensing Study, NACDS, NASP, NCPA
Leading Headlines, Pharmacy
WASHINGTON – Pharmacy reimbursement paid by state Medicaid programs requires a fresh look and modernization, according to a new Cost of Dispensing Study commissioned by the National Association of Chain Drug Stores (NACDS), the National Community Pharmacists Association (NCPA) and the National Association of Specialty Pharmacy (NASP). DOWNLOAD STUDY DOWNLOAD Q&A In
February 6, 2020 by Chain Drug Review
Brian Caswell, coronavirus, NCPA
Leading Headlines, Pharmacy
ALEXANDRIA, Va. – Americans are much more worried about the Coronavirus than their local pharmacists, according to a national survey, and they’re snapping up surgical masks faster than the stores can get them. “The news coverage is clearly affecting consumer behavior,” said Brian Caswell, president of the National Community Pharmacists Association and owner of Wolkar
January 21, 2020 by Chain Drug Review
Centers for Medicare & Medicaid Services, National Community Pharmacists Association, NCPA, Ronna Hauser
Leading Headlines, Pharmacy
ALEXANDRIA, Va. — In comments to the Centers for Medicare & Medicaid Services, the National Community Pharmacists Association urged the agency to enhance coverage of pharmacist-provided care services and reevaluate strict supervision requirements as well as coverage policies for incident-to services. In response to President Trump’s Executive Order #13890 on Protecting and Improving Medicare for
January 14, 2020 by B. Douglas Hoey
B. Douglas Hoey, NCPA, pharmacy
January 6, 2020, Opinion
One thing that can be said about the state of prescription medications in 2019 is that the pharmacy payment model is complex, convoluted and confusing. That’s how I began this column last year. And although some progress has been made in moving the model toward a system that better serves patients, that sentence still does